Article
Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex vivo Organ Perfusion
18 Feb 2020
Abstract excerpt
Organ gene therapy represents a promising tool to correct diseases or improve graft survival after transplantation. Polymorphic variation of the major histocompatibility complex (MHC) antigens remains a major obstacle to long-term graft survival after transplantation. Previously, we demonstrated that MHC-silenced cells are protected against allogeneic immune responses. We also showed the feasibility to silence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
